Denali Therapeutics (DNLI)
NASDAQ:DNLI
Want to see DNLI full AI Analyst Report?
Denali Therapeutics (DNLI) Ownership Overview
6.65% Insiders
23.74% Mutual Funds
40.65% Other Institutional Investors
16.42% ETFs
12.55% Public Companies and
Individual Investors
The ownership structure of Denali Therapeutics (DNLI) stock is a mix of institutional, retail, and individual investors. Approximately 80.81% of the company’s stock is owned by Institutional Investors, 6.65% is owned by Insiders, and 12.55% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 08, 2026 | xxxxxxxxxxxxx | $284097 | |
Jan 08, 2026 | xxxxxxxxxxxxx | $580767 | |
Aug 14, 2025 | xxxxxxxxxxxxx | $39884 | |
Aug 14, 2025 | xxxxxxxxxxxxx | $39884 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2024 | xxxxxxxxxxxxx | $6990374 | |
Mar 31, 2024 | xxxxxxxxxxxxx | $46788384 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,022,297 | Institution | 7.58% | 224,095,616 | |
| 10,475,117 | Institution | 6.60% | 195,256,181 | |
| 6,543,779 | Institution | 4.12% | 121,976,041 | |
| 3,731,695 | Institution | 2.35% | 69,558,795 | |
| 3,455,300 | Institution | 2.18% | 64,406,792 | |
| 3,419,991 | Institution | 2.15% | 63,748,632 | |
| 3,415,958 | Insider | 2.15% | 63,673,457 | |
| 2,449,437 | Insider | 1.54% | 45,657,506 | |
| 2,436,895 | Institution | 1.54% | 45,423,723 | |
| 2,309,009 | Institution | 1.45% | 43,039,928 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,475,117 | Institution | 6.60% | 195,256,181 | |
| 3,455,300 | Institution | 2.18% | 64,406,792 | |
| 2,309,009 | Institution | 1.45% | 43,039,928 | |
| 2,182,159 | Institution | 1.37% | 40,675,444 | |
| 2,179,111 | Institution | 1.37% | 40,618,629 | |
| 1,755,149 | Institution | 1.11% | 32,715,977 | |
| 1,452,550 | Institution | 0.92% | 27,075,532 | |
| 1,254,127 | Institution | 0.79% | 23,376,927 | |
| 1,208,732 | Institution | 0.76% | 22,530,764 | |
| 1,184,610 | Institution | 0.75% | 22,081,130 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,243,773 | Institution | 2.67% | 81,480,442 | |
| 3,324,677 | Institution | 2.09% | 64,698,214 | |
| 3,133,682 | Institution | 1.97% | 61,639,525 | |
| 3,112,100 | Institution | 1.96% | 59,752,320 | |
| 1,738,573 | Institution | 1.10% | 33,380,602 | |
| 1,656,560 | Institution | 1.04% | 31,805,952 | |
| 1,147,645 | Institution | 0.72% | 22,333,172 | |
| 1,042,239 | Institution | 0.66% | 20,281,971 | |
| 724,251 | Institution | 0.46% | 14,246,017 | |
| 701,024 | Institution | 0.44% | 13,459,661 |
FAQ
Who Owns Denali Therapeutics (DNLI)?
According to the latest TipRanks data, approximately 40.65% of the company's stock is held by institutional investors, 6.65% is held by insiders, and 12.55% is held by retail investors.
What percentage of Denali Therapeutics (DNLI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 40.65% of Denali Therapeutics (DNLI) stock is held by institutional investors.
What percentage of Denali Therapeutics (DNLI) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.55% of Denali Therapeutics (DNLI) stock is held by retail investors.
Who owns the most shares of Denali Therapeutics (DNLI)?
Vanguard owns the most shares of Denali Therapeutics (DNLI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.